Bandingkan Harga & Kinerja Indonesia Kendaraan Terminal Tbk (IPCC) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indonesia Kendaraan Terminal Tbk dan Organon Pharma Indonesia Tbk.: Indonesia Kendaraan Terminal Tbk diperdagangkan di Rp1.125 (kapitalisasi pasar 2,05 T, volume 24 jam 770 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indonesia Kendaraan Terminal Tbk jauh lebih besar — sekitar 19,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IPCC | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,05 T | 104,4 M |
Volume | 770 rb | — |
Lot | 7,7 rb | — |
Perputaran | 864,05 jt | — |
Harga Rata-rata | 1.122,14 | — |
Nilai Transaksi | 864,05 jt | — |
Harga Ekuilibrium Indikatif | 1.125 | — |
Volume Ekuilibrium Indikatif | 20 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indonesia Kendaraan Terminal Tbk
PT Indonesia Kendaraan Terminal Tbk (“the Company”) was established based on November 05, 2012 by deed No. 10 of Yulianti Irawati SH., substitute of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., Notary in Jakarta. Prior to becoming a separate business entity, PT Indonesia Vehicle Terminal was only a strategic business unit called Tanjung Priok Car Terminal (TPT) under its Head Office and operated since June 2007.
Selengkapnya di halaman IPCC →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
